Skip to main content

Company Comparison

Gilgamesh Pharmaceutical vs BioAnalytics

Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.

MetricGilgamesh PharmaceuticalBioAnalytics
SectorBiotechBiotech
HeadquartersBoston
Founded
StatusActiveActive
Last Funding StageSeries B
Total Funding$55M
Valuation

What They Build

Gilgamesh Pharmaceutical

Gilgamesh Pharmaceuticals is a pharmaceutical company that is developing psychedelic and related drugs as medicines.

BioAnalytics

Boston-based biotech company developing analytics and data solutions for the life sciences industry.

Key Investors

Gilgamesh Pharmaceutical

BioAnalytics

No investors listed.

Sector Overlap

Both Gilgamesh Pharmaceutical and BioAnalytics operate in Biotech.

Browse all Biotech companies →

Websites

Sponsored
AArchstone

The operating system for private capital.

Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.

LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees

14-day free trial. No credit card required.